Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
NCT06721234 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-12-10
Summary
Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations
Conditions
- Behçet
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 19 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-12-02
- Primary Completion
- 2025-04-30
- Completion
- 2025-07-30
Countries
- Egypt
Study Locations
More Related Trials
-
Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
NCT07276087 ·Status: RECRUITING
-
VCRC Patient Contact Registry Patient-Reported Data Validation Study
NCT02190942 ·Status: COMPLETED
-
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
NCT03371095 ·Status: COMPLETED ·Phase: PHASE3
-
Journey of Patients With Vasculitis From First Symptom to Diagnosis
NCT03410290 ·Status: COMPLETED
-
Detection of Subclinical Enthesitis by Ultrasonography
NCT04209894 ·Status: COMPLETED
-
MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE
NCT01780363 ·Status: COMPLETED
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
NCT06145893 ·Status: RECRUITING ·Phase: PHASE3
-
Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
NCT04105439 ·Status: UNKNOWN
-
Eosinophil and Anticoagulation in COVID-19 Patients
NCT04507282 ·Status: COMPLETED
-
FMF and Atheroscelerosis
NCT06047938 ·Status: NOT_YET_RECRUITING
-
Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study
NCT05059184 ·Status: COMPLETED
-
1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
NCT02756650 ·Status: COMPLETED ·Phase: PHASE2
-
Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort
NCT01446380 ·Status: UNKNOWN
-
To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
NCT00302549 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Two Treatments in the Remission of Vasculitis
NCT00748644 ·Status: COMPLETED ·Phase: PHASE3
-
Mobile App-Based Infection Monitoring in Familial Mediterranean Fever
NCT07212764 ·Status: ENROLLING_BY_INVITATION
-
Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema
NCT04963634 ·Status: TERMINATED
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
NCT00001764 ·Status: COMPLETED ·Phase: PHASE1
-
Vasculitis Illness Perception (VIP) Study
NCT02190916 ·Status: COMPLETED
-
Multicenter Cohort Study of AAV in Hunan of China
NCT05315141 ·Status: RECRUITING
-
Efficacy of Upadacitinib After NECS in Vitiligo
NCT06454461 ·Status: RECRUITING ·Phase: NA
-
Cytokines in Blister Fluids of Bullous Pemphigoid (BP)
NCT03856840 ·Status: COMPLETED
-
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
NCT06894602 ·Status: RECRUITING